NCT06219122 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Bohlmeijer E, Westerhof G
The Model for Sustainable Mental Health: Future Directions for Integrating Positive Psychology Into Mental Health Care. Front Psychol. 2021 Oct 21;12:747999. doi: 10.3389/fpsyg.2021.747999. eCollection 2021.
Franken K, Schuffelen P, Ten Klooster P, van Doesum K, Westerhof G, Bohlmeijer E
Introduction of the generic sense of ability to adapt scale and validation in a sample of outpatient adults with mental health problems. Front Psychol. 2023 Mar 29;14:985408. doi: 10.3389/fpsyg.2023.985408. eCollection 2023.
Franken, C
P.M., Vos, J.A. de, Westerhof, G.J., & Bohlmeijer, E. (2019). De Mental Health Continuum Short Form (MHC-SF), een handleiding voor behandelaren in de geestelijke gezondheidszorg voor het interpreteren en bespreken van scores met patiënten. Enschede; Universiteit Twente.

The Effectiveness of a Creative Arts en Psychomotor Therapy Intervention for People With Personality Disorders to Enhance Psychological Adaptation and Wellbeing, a Multiple Baseline Single Case Experimental Design.

Details for clinical trial NCT06219122

Clinical trial NCT06219122 - References